Abstract
AbstractHyperornithinaemia with gyrate atrophy of choroid and retina (HOGA) is a recessive metabolic disease caused by dysfunction of the ornithine aminotransferase (OAT) gene, leading to ornithine accumulation and a complex metabolic imbalance. This causes retinal degeneration that ultimately evolve to blindness. However, the mechanisms of this degeneration remain unknown. Here, we have conducted untargeted metabolomic analysis in patient-derived induced pluripotent stem cells and their isogenic counterparts. Mutant cells show altered levels of ornithine-related metabolites, including low creatine, proline and glutamate, and elevated arginine and citrulline. The untargeted metabolomics approach revealed changes in the urea cycle and polyamine synthesis pathways with a significant intracellular accumulation of gamma-aminobutyric acid (GABA). Hence, we propose GABA as a key player in the disease pathogenicity, potentially affecting neuronal function in the eye.
Publisher
Cold Spring Harbor Laboratory
Reference28 articles.
1. Kaiser-Kupfer, M. , Kuwabara, T. , Uga, S. , Takki, K. & Valle, D. Cataract in gyrate atrophy: Clinical and morphologic studies. Investigative Ophthalmology and Visual Science (1983).
2. Sipilä, I. , Valle, D. , Mitchell, G. A. & Brody, L. C. Hyperornithinemia and gyrate atrophy: ornithine aminotransferase gene error causing a Finnish disease.
3. Muscle creatine phosphate in gyrate atrophy of the choroid and retina with hyperornithinaemia-clues to pathogenesis
4. The Finnish genetic heritage in 2022 – from diagnosis to translational research;Dis. Model. Mech,2022
5. An initiator codon mutation in ornithine-delta-aminotransferase causing gyrate atrophy of the choroid and retina.